Bringing the Oncology Community Together

iTunes

YouTube

Google Plus

Login | Register

Home

CME

Urology

Research

iPubs

Meetings

Blogs

Practice Management

Partners

Introduction: Advances and Issues in NSCLC

Panelists: David R. Gandara, MD, UC Davis; Corey J. Langer, MD, Penn Medicine;
Alan B. Sandler, MD, OHSU; Mark A. Socinski, MD, University of Pittsburgh;
Anne S. Tsao, MD, MD Anderson

Published Online: Tuesday, January 22, 2013

For High-Definition, Click

In the first installment of the series, the moderator, David R. Gandara, MD, provides an overview of the topics that will be discussed by the panel, which includes: Corey J. Langer, MD, Alan B. Sandler, MD, Mark A. Socinski, MD, and Anne S. Tsao, MD.

Gandara notes that this Peer Exchange discussion will focus on a range of issues and challanges facing physicians who treat patients with lung cancer. Specifically, the panel will examine new therapies and testing for molecular abnormalities and the integration of these test results into the treatment decision making process.

View More From This Discussion

▼ Episode 1 Introduction: Advances and Issues in NSCLC

Introduction: Advances and Issues in NSCLC

In the first installment of the series, the moderator, David R. Gandara, MD, provides an overview of the topics that will be discussed by the panel, which includes: Corey J. Langer, MD, Alan B. Sandler, MD, Mark A. Socinski, MD, and Anne S. Tsao, MD.

View Episode >>>

► Episode 2 Best Practices in NSCLC Molecular Testing, Part I

Best Practices in NSCLC Molecular Testing, Part I

Alan B. Sandler, MD, Mark A. Socinski, MD, Corey J. Langer, MD, and Anne S. Tsao, MD, discuss the best practices for treating non-small cell lung cancer.

View Episode >>>

► Episode 3 Best Practices in NSCLC Molecular Testing, Part II

Best Practices in NSCLC Molecular Testing, Part II

Alan B. Sandler, MD, Mark A. Socinski, MD, Corey J. Langer, MD, and Anne S. Tsao, MD, discuss the best practices for treating non-small cell lung cancer.

View Episode >>>

► Episode 4 Molecular Testing and Actionable Targets in NSCLC

Molecular Testing and Actionable Targets in NSCLC

In this segment, Mark A. Socinski, MD, addresses the topic of which molecular tests should be administered in lung cancer.

View Episode >>>

► Episode 5 Concurrent Versus Sequential Testing in NSCLC

Concurrent Versus Sequential Testing in NSCLC

Corey J. Langer, MD, Alan B. Sandler, MD, Mark A. Socinski, MD, Anne S. Tsao, MD, and David Gandara, MD, discuss concurrent versus sequential testing in non-small cell lung cancer.

View Episode >>>

► Episode 6 Rebiopsying and Molecular Testing in NSCLC

Rebiopsying and Molecular Testing in NSCLC

Anne S. Tsao, MD, Mark A. Socinski, MD, Corey J. Langer, MD, Alan B. Sandler, MD, and David Gandara, MD, discuss molecular testing and re-biopsying in non-small cell lung cancer.

View Episode >>>

► Episode 7 Selecting a Laboratory for Molecular Testing in NSCLC

Selecting a Laboratory for Molecular Testing in NSCLC

In this segment, the panelists discuss choosing the most appropriate laboratory for molecular testing in order to avoid invalid test results

View Episode >>>

► Episode 8 Selecting Treatment for First- Line Non-Squamous NSCLC

Selecting Treatment for First- Line Non-Squamous NSCLC

The challenge facing many physicians who treat advanced non-small cell lung cancer is determining the optimal approach for treating patients with non-squamous histology.

View Episode >>>

► Episode 9 Squamous Cell Carcinoma Treatment Options

Squamous Cell Carcinoma Treatment Options

Corey J. Langer, MD, Mark A. Socinski, MD, Anne S. Tsao, MD, and David Gandara, MD, discuss treatment options for patients with squamous cell carcinoma.

View Episode >>>

► Episode 10 Molecular Heterogeneity in Non-Small Cell Lung Cancer

Molecular Heterogeneity in Non-Small Cell Lung Cancer

In this segment, Alan B. Sandler, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Mark A. Socinski, MD, and David Gandara, MD, discuss the heterogeneity of molecular characteristics in non-small cell lung cancer.

View Episode >>>

► Episode 11 Promising Emerging Classes of Therapies in NSCLC

Promising Emerging Classes of Therapies in NSCLC

David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, discuss emerging therapies in non-small cell lung cancer.

View Episode >>>

► Episode 12 Access to Molecular Testing Therapy in NSCLC

Access to Molecular Testing Therapy in NSCLC

Alan B. Sandler, MD, Corey J. Langer, MD, Anne S. Tsao, MD, David Gandara, MD, and Mark A. Socinski, MD, discuss access to molecular testing in advanced non-small cell lung cancer.

View Episode >>>

► Episode 13 Personalizing the Treatment of Lung Cancer

Personalizing the Treatment of Lung Cancer

Anne S. Tsao, MD, Mark A. Socinski, MD, Corey J. Langer, MD, Alan B. Sandler, MD, and David Gandara, MD, discuss molecular testing and the treatment decision-making process.

View Episode >>>

► Episode 14 Impact of EGFR Mutations on Treatment Decisions in NSCLC

Impact of EGFR Mutations on Treatment Decisions in NSCLC

Anne S. Tsao, MD, David Gandara, MD, Corey A. Langer, MD, Mark A. Socinski, MD, and Alan B. Sandler, MD, discuss common mutations and their treatments in lung cancer.

View Episode >>>

► Episode 15 The Cost-Effectiveness of Targeted Therapies in NSCLC

The Cost-Effectiveness of Targeted Therapies in NSCLC

Alan B. Sandler, MD, Corey J. Langer, MD, Mark A. Socinski, MD, and David Gandara, MD, discuss cost-effectiveness of molecular testing and targeted therapies.

View Episode >>>

Expert Panelists

David R. Gandara

David R. Gandara, MD

Moderator
Director, Thoracic Oncology Program,
University of California, Davis Comprehensive Cancer Center
Sacramento, California

Corey J. Langer, MD

Director, Thoracic Oncology, The University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania

Alan B. Sandler, MD

Professor of Medicine in Hematology & Oncology, Oregon Health & Science University
Portland, Oregon

Mark A. Socinski, MD

Director, Lung Cancer Section, Division of Hematology/Oncology, University of Pittsburgh
Pittsburgh, Pennsylvania

Anne S. Tsao, MD

Director, Mesothelioma Program, The University of Texas MD Anderson Comprehensive Cancer Center
Houston, Texas

Management of Hodgkin Lymphoma

Advances in Colorectal Cancer

Management of Neuroendocrine Tumors

Advances and Issues in NSCLC

Effective Management of Prostate Cancer

Managing Metastatic Breast Cancer

Advances and Issues of Early Breast Cancer

Prostate Cancer: Practice Management

Urologists in Cancer Care: Focus on Prostate Cancer

Related Videos

Dr. Camidge on Targeted Therapies in Adjuvant NSCLC

Dr. Herbst on Selecting Patients for Molecular Testing

The Cost-Effectiveness of Targeted Therapies in NSCLC

Impact of EGFR Mutations on Treatment Decisions in NSCLC

Personalizing the Treatment of Lung Cancer

Access to Molecular Testing Therapy in NSCLC

The content contained in this video is for general information purposes only. The viewer is encouraged to confirm the information presented with other sources. OncLiveTV Peer Exchange makes no representations or warranties of any kind about the completeness, accuracy, timeliness, reliability, or suitability of any of the information, including content or advertisements, contained in this video and expressly disclaims liability for any errors and omissions that may be presented in this video. OncLiveTV Peer Exchange reserves the right to alter or correct any error or omission in the information it provides in this video, without any obligations. OncLiveTV Peer Exchange further disclaims any and all liability for any direct, indirect, consequential, special, exemplary, or other damages arising from the use or misuse of any material or information presented in this video. The views expressed in this video are those of the panelists and do not necessarily reflect the opinion or policy of OncLiveTV Peer Exchange.

External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedHC

OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2013
Intellisphere, LLC. All Rights Reserved.